Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas
Technology
E-302-2000
Patent ID
E-302-2000-2-EP-06
Country
EP
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
1365796
Application Number
01968307.7
IC
NCI
Date Filed
Date Issued
Patent PDF